Serum NLRC3 levels are markedly lower in patients with pulmonary hypertension, and correlate with results from other diagnostic tests, researchers from China report. This study with that finding, “NLRC3: A Novel Noninvasive Biomarker for Pulmonary Hypertension Diagnosis,” was published in the journal Aging and Disease. Right heart…
The nonprofit organization Team PHenomenal Hope is welcoming applications for $500 micro-grants awarded through a program that aims to help cover the non-medical needs of pulmonary hypertension (PH) patients. Grants given through the Team PH Unmet Needs Patient Impact Fund are intended to cover expenses such as groceries, travel and lodging…
A new procedure, performed at Northwestern Memorial Hospital in Illinois, successfully treated a patient with pulmonary hypertension (PH) caused by blood clots formed in the lung vessels, a condition referred to as chronic thromboembolic pulmonary hypertension (CTEPH).
A large review of clinical trials evaluating whether pulmonary hypertension (PH)-targeted therapies can improve exercise capacity in patients with pulmonary hypertension due to left heart disease (PH-LHD) found varying effectiveness and modest benefit. The findings were reported in the study “Pulmonary hypertension-targeted therapies in heart failure: A systematic…
Patients with systemic sclerosis (SSc) at risk of having pulmonary hypertension (PH) also have similar risk factors for a poorer outcome as patients with SSc-PH and SSc-pulmonary arterial hypertension (PAH), a study shows. Being male, having accumulation of fluids around the heart, low oxygen desaturation during exercise, and reduced…
Bellerophon Therapeutics has announced positive data from its Phase 3 clinical trial investigating INOpulse in patients with pulmonary arterial hypertension (PAH), as well as the enrollment of the first group of patients in its Phase 2b study testing INOpulse in patients with pulmonary hypertension associated with interstitial lung…
Half a year has gone by since disgraced pharma executive Martin Shkreli was sentenced to seven years in federal prison for securities and wire fraud while heading San Diego-based Retrophin. As founder and CEO of another company (then known as Turing Pharmaceuticals), in late 2015 Shkreli bought the rights…
A new study identified two potential therapeutic targets for pulmonary hypertension (PH) associated with heart failure. The two related enzymes, named ROCK1 and ROCK2, were seen to exert opposing effects on heart muscle cells, either preventing or promoting PH, in mouse models of…
Long-term use of ralinepag, an investigational therapy being developed by Arena Pharmaceuticals, can promote positive changes in the outcome of patients with pulmonary arterial hypertension (PAH), interim data from a Phase 2 extension trial shows. After taking oral ralinepag for a median of up to 1.8 years, patients continued…
Inspiratory muscle weakness aggravates shortness of breath caused by exertion and lung function capacity in patients with chronic thromboembolic pulmonary hypertension, a study has found. The study, “Inspiratory muscle weakness contributes to exertional dyspnea in chronic thromboembolic pulmonary hypertension,” was published in the journal PLOS One. CTEPH is a…
Drinking nitrate-rich beetroot juice can improve the production of nitric oxide in patients with pulmonary arterial hypertension (PAH), a small clinical trial shows. Data from the trial was reported in the study, “Effects of oral supplementation with nitrate-rich beetroot juice in patients with pulmonary arterial hypertension…
Arterial stiffness, a marker of atherosclerosis, is significantly greater in patients with chronic thromboembolic pulmonary hypertension (CTEPH) compared to people with other diseases that also put them at risk of atherosclerosis, researchers report. The study, “Increased systemic arterial stiffness in patients with chronic thromboembolic pulmonary hypertension,” was published…
Get regular updates to your inbox.